Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (44)

« Back to Publications

Phase II multicentre double-blind randomised controlled trial of a Bivalent VaccInation against Salmonella Typhi and Paratyphi A (BiVISTA) using a controlled human infection model of paratyphoid A infection: study protocol.

Paganotti Vicentine M. et al, (2026), BMJ Open, 16

Persistence of Immune Responses 5 Years After Vaccination With a Single Dose of Typhoid Conjugate Vaccine (TCV) in Nepalese Children

Pant D. et al, (2026)

Impact of Dosing Interval on Immunogenicity Following a Heterologous Typhoid Conjugate Vaccine Booster in Nepalese Children: An Observational Study

Zhang Y. et al, (2026)

Eight-Year Vaccine Protection Following a Single Dose of VI-Tetanus Toxoid Conjugate Vaccine in Nepali Children: Extended Follow-Up of the TyVAC Nepal Randomised Controlled Trial

Pant D. et al, (2026)

Safety, Efficacy, and Immunogenicity of a Salmonella Paratyphi A Vaccine.

McCann N. et al, (2025), N Engl J Med, 393, 1704 - 1714

Leveraging paired serology to estimate the incidence of typhoidal Salmonella infection in the STRATAA study.

Walker J. et al, (2025), PLoS Negl Trop Dis, 19

Recent Advances in Vaccine Development for Flaviviruses and Alphaviruses.

Kim YC. and Reyes-Sandoval A., (2025), Vaccines (Basel), 13

Author Correction: Immunogenic recombinant Mayaro virus-like particles present natively assembled glycoprotein.

Kim YC. et al, (2025), NPJ Vaccines, 10

Heterologous prime-boost Zika virus vaccination induces comprehensive humoral and cellular immunity in mouse models.

De Lorenzo G. et al, (2025), Front Immunol, 16

Immunogenic recombinant Mayaro virus-like particles present natively assembled glycoprotein.

Kim YC. et al, (2024), NPJ Vaccines, 9

5-year vaccine protection following a single dose of Vi-tetanus toxoid conjugate vaccine in Bangladeshi children (TyVOID): a cluster randomised trial.

Qadri F. et al, (2024), Lancet, 404, 1419 - 1429

Mayaro Virus: An Emerging Alphavirus in the Americas.

Wei LLL. et al, (2024), Viruses, 16

Advances in Alphavirus and Flavivirus Research.

Kim YC. and Reyes-Sandoval A., (2024), Viruses, 16

The safety and immunogenicity of a bivalent conjugate vaccine against Salmonella enterica Typhi and Paratyphi A in healthy Indian adults: a phase 1, randomised, active-controlled, double-blind trial.

Kulkarni PS. et al, (2024), Lancet, 403, 1554 - 1562

Immune responses to typhoid conjugate vaccine in a two dose schedule among Nepalese children <2 years of age.

Bijukchhe SM. et al, (2024), Vaccine, 42, 2018 - 2025

Load More